Clinical Trial Update: A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Vehicle in Subjects With Blepharitis (P08636) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating azithromycin ophthalmic solution 1% versus vehicle for blepharitis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blepharitis

Drugs mentioned

• AZASITE (AZITHROMYCIN MONOHYDRATE)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Blepharitis | Phase 2 | Status: TERMINATED